106 related articles for article (PubMed ID: 22444164)
1. Enhancement of anticancer efficacy of chemotherapeutics by gambogic acid against gastric cancer cells.
Zou ZY; Wei J; Li XL; Yu LX; Wang TT; Qian XP; Liu BR
Cancer Biother Radiopharm; 2012 Jun; 27(5):299-306. PubMed ID: 22444164
[TBL] [Abstract][Full Text] [Related]
2. Synergistic interaction between tetrandrine and chemotherapeutic agents and influence of tetrandrine on chemotherapeutic agent-associated genes in human gastric cancer cell lines.
Wei J; Liu B; Wang L; Qian X; Ding Y; Yu L
Cancer Chemother Pharmacol; 2007 Oct; 60(5):703-11. PubMed ID: 17256130
[TBL] [Abstract][Full Text] [Related]
3. Synergistic anti-proliferative effects of gambogic acid with docetaxel in gastrointestinal cancer cell lines.
Zou Z; Xie L; Wei J; Yu L; Qian X; Chen J; Wang T; Liu B
BMC Complement Altern Med; 2012 Apr; 12():58. PubMed ID: 22546220
[TBL] [Abstract][Full Text] [Related]
4. Gambogic acid, a potent inhibitor of survivin, reverses docetaxel resistance in gastric cancer cells.
Wang T; Wei J; Qian X; Ding Y; Yu L; Liu B
Cancer Lett; 2008 Apr; 262(2):214-22. PubMed ID: 18248784
[TBL] [Abstract][Full Text] [Related]
5. Synergistic effect of 5-fluorouracil with gambogic acid on BGC-823 human gastric carcinoma.
Wang J; Liu W; Zhao Q; Qi Q; Lu N; Yang Y; Nei FF; Rong JJ; You QD; Guo QL
Toxicology; 2009 Feb; 256(1-2):135-40. PubMed ID: 19084572
[TBL] [Abstract][Full Text] [Related]
6. Anticancer effect and apoptosis induction of gambogic acid in human gastric cancer line BGC-823.
Liu W; Guo QL; You QD; Zhao L; Gu HY; Yuan ST
World J Gastroenterol; 2005 Jun; 11(24):3655-9. PubMed ID: 15968715
[TBL] [Abstract][Full Text] [Related]
7. Rofecoxib augments anticancer effects by reversing intrinsic multidrug resistance gene expression in BGC-823 gastric cancer cells.
Zhu FS; Chen XM; Huang ZG; Wang ZR; Zhang DW; Zhang X
J Dig Dis; 2010 Feb; 11(1):34-42. PubMed ID: 20132429
[TBL] [Abstract][Full Text] [Related]
8. Cinnamaldehyde/chemotherapeutic agents interaction and drug-metabolizing genes in colorectal cancer.
Yu C; Liu SL; Qi MH; Zou X
Mol Med Rep; 2014 Feb; 9(2):669-76. PubMed ID: 24276478
[TBL] [Abstract][Full Text] [Related]
9. [Differential gene expression of the inhibitor of apoptosis proteins in docetaxel-resistant gastric cancer cells].
Wang TT; Wei J; Qian XP; Yu LX; Liu BR
Zhonghua Zhong Liu Za Zhi; 2008 Aug; 30(8):573-7. PubMed ID: 19102932
[TBL] [Abstract][Full Text] [Related]
10. [Synergistic interaction between melittin and chemotherapeutic agents and their possible mechanisms: an experimental research].
Wang RP; Huang SR; Zhou JY; Zou X
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2014 Feb; 34(2):224-9. PubMed ID: 24672950
[TBL] [Abstract][Full Text] [Related]
11. Synergistic interaction between tetra-arsenic oxide and paclitaxel in human cancer cells in vitro.
Chung WH; Sung BH; Kim SS; Rhim H; Kuh HJ
Int J Oncol; 2009 Jun; 34(6):1669-79. PubMed ID: 19424586
[TBL] [Abstract][Full Text] [Related]
12. Effects of the proteasome inhibitor bortezomib alone and in combination with chemotherapeutic agents in gastric cancer cell lines.
Bae SH; Ryoo HM; Kim MK; Lee KH; Sin JI; Hyun MS
Oncol Rep; 2008 Apr; 19(4):1027-32. PubMed ID: 18357392
[TBL] [Abstract][Full Text] [Related]
13. Antitumor efficacy of sequential treatment with docetaxel and 5-fluorouracil against human oral cancer cells.
Tamatani T; Ferdous T; Takamaru N; Hara K; Kinouchi M; Kuribayashi N; Ohe G; Uchida D; Nagai H; Fujisawa K; Miyamoto Y
Int J Oncol; 2012 Sep; 41(3):1148-56. PubMed ID: 22766915
[TBL] [Abstract][Full Text] [Related]
14. In-vitro schedule-dependent interaction between oxaliplatin and 5-fluorouracil in human gastric cancer cell lines.
Qin B; Tanaka R; Shibata Y; Arita S; Ariyama H; Kusaba H; Baba E; Harada M; Nakano S
Anticancer Drugs; 2006 Apr; 17(4):445-53. PubMed ID: 16550003
[TBL] [Abstract][Full Text] [Related]
15. Synergistic effects of docetaxel and S-1 by modulating the expression of metabolic enzymes of 5-fluorouracil in human gastric cancer cell lines.
Wada Y; Yoshida K; Suzuki T; Mizuiri H; Konishi K; Ukon K; Tanabe K; Sakata Y; Fukushima M
Int J Cancer; 2006 Aug; 119(4):783-91. PubMed ID: 16557585
[TBL] [Abstract][Full Text] [Related]
16. Synergistic anticancer effects of polyphyllin I and evodiamine on freshly-removed human gastric tumors.
Yue G; Wei J; Qian X; Yu L; Zou Z; Guan W; Wang H; Shen J; Liu B
PLoS One; 2013; 8(6):e65164. PubMed ID: 23762305
[TBL] [Abstract][Full Text] [Related]
17. Synergistic antitumor effects of dasatinib and oxaliplatin in gastric cancer cells.
Shi M; Lou B; Ji J; Shi H; Zhou C; Yu Y; Liu B; Zhu Z; Zhang J
Cancer Chemother Pharmacol; 2013 Jul; 72(1):35-44. PubMed ID: 23712327
[TBL] [Abstract][Full Text] [Related]
18. UCN-01 suppresses thymidylate synthase gene expression and enhances 5-fluorouracil-induced apoptosis in a sequence-dependent manner.
Hsueh CT; Kelsen D; Schwartz GK
Clin Cancer Res; 1998 Sep; 4(9):2201-6. PubMed ID: 9748140
[TBL] [Abstract][Full Text] [Related]
19. Docetaxel-ST1481 sequence exerts a potent cytotoxic activity on hormone-resistant prostate cancer cells by reducing drug resistance-related gene expression.
Fabbri F; Brigliadori G; Carloni S; Ulivi P; Tesei A; Silvestrini R; Amadori D; Zoli W
Prostate; 2010 Feb; 70(2):219-27. PubMed ID: 19790230
[TBL] [Abstract][Full Text] [Related]
20. In-vitro effect of a combination of 5-fluorouracil (5-FU) and cisplatin (CDDP) on human gastric cancer cell lines: timing of cisplatin treatment.
Cho H; Imada T; Oshima T; Shiozawa M; Rino Y; Takanashi Y
Gastric Cancer; 2002; 5(1):43-6. PubMed ID: 12021859
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
